3-Bromo-4-(trifluoromethyl)pyridine, 98.0%, 1g

Cyclohexyldiphenylphosphine, 95.0%, 100g

ETHYL 3-BROMOPYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLATE, 97.0%, 1g

Acétate d'éthyle, min 99,5 %, pour la synthèse, 2,5 L, emballage en verre

6-hydrazinyl-3,4-dihydropyrimidin-4-one, 95%, 10g

6-Chloro-2-(pyridin-2-yl)pyrimidin-4-amine, 95.0%, 1g

Rebastinib, 99.91%, 50mg

Bisphenol A diglycidyl ether, 84.0%, 100g

Nitrate de sodium, min 99%, pa, ACS, ISO, 5 kg, emballage plastique.

4-(Octylamino)pyridine, 95.0%, 25g

4-Bromo-5-chloro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

4-Amino-7-bromoisoindolin-1-one, 97%, 250mg

6-Chloro-3-hydroxypyrazine-2-carboxamide, 95.0%, 250mg